---
figid: PMC6366304__JCO.2014.59.0018f1
figlink: /pmc/articles/PMC6366304/figure/F1/
number: F1
caption: Common PI3K pathway aberrations found in a variety of solid tumor types.
  Activation of the PI3K pathway contributes to tumor growth, survival, and resistance
  to anticancer therapies. FGFR2, fibroblast growth factor receptor 2; GBM, glioblastoma
  multiforme; HER2, human epidermal growth factor receptor 2; HNSCC, head and neck
  squamous cell carcinoma; INPP4B, inositol polyphosphate 4-phosphatase type II; MET,
  hepatocyte growth factor receptor; mTORC, mammalian target of rapamycin complex;
  NSCLC, non–small-cell lung cancer; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol
  4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
  and tensin homolog; PTPN12, protein tyrosine phosphatase nonreceptor 12; RTK, receptor
  tyrosine kinase; SCLC, small-cell lung cancer; TNBC, triple-negative breast cancer.
  Adapted from a figure provided by Ana Maria Gonzalez-Angulo.
pmcid: PMC6366304
papertitle: Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.
reftext: Patricia Mucci LoRusso. J Clin Oncol. 2016 Nov 1;34(31):3803-3815.
pmc_ranked_result_index: '98502'
pathway_score: 0.8770816
filename: JCO.2014.59.0018f1.jpg
figtitle: Common PI3K pathway aberrations found in a variety of solid tumor types
year: '2016'
organisms: Homo sapiens
ndex: 4552e893-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6366304__JCO.2014.59.0018f1.html
  '@type': Dataset
  description: Common PI3K pathway aberrations found in a variety of solid tumor types.
    Activation of the PI3K pathway contributes to tumor growth, survival, and resistance
    to anticancer therapies. FGFR2, fibroblast growth factor receptor 2; GBM, glioblastoma
    multiforme; HER2, human epidermal growth factor receptor 2; HNSCC, head and neck
    squamous cell carcinoma; INPP4B, inositol polyphosphate 4-phosphatase type II;
    MET, hepatocyte growth factor receptor; mTORC, mammalian target of rapamycin complex;
    NSCLC, non–small-cell lung cancer; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol
    4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PTEN, phosphatase
    and tensin homolog; PTPN12, protein tyrosine phosphatase nonreceptor 12; RTK,
    receptor tyrosine kinase; SCLC, small-cell lung cancer; TNBC, triple-negative
    breast cancer. Adapted from a figure provided by Ana Maria Gonzalez-Angulo.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - FGFR2
  - AKT1
  - PIK3CA
  - ERBB2
  - INPP4B
  - PIK3CB
  - MTOR
  - RPTOR
  - SART3
  - AKT3
  - PIK3R5
  - PIK3R4
  - PIK3CD
  - PTPN12
  - PIK3CG
  - MET
  - PIK3R3
  - PIK3R6
  - PIK3R1
  - PTEN
  - Cancer
genes:
- word: AKT1/2
  symbol: AKT2
  source: hgnc_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FGFR2
  symbol: FGFR2
  source: hgnc_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: INPP4B
  symbol: INPP4B
  source: hgnc_symbol
  hgnc_symbol: INPP4B
  entrez: '8821'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT1/2
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PIK3CA
  symbol: PIK3CA
  source: hgnc_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PTPN12
  symbol: PTPN12
  source: hgnc_symbol
  hgnc_symbol: PTPN12
  entrez: '5782'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PIK3R1/2
  symbol: PIK3R1
  source: hgnc_symbol
  hgnc_symbol: PIK3R1
  entrez: '5295'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6366304__F1
redirect_from: /figures/PMC6366304__F1
figtype: Figure
---
